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ABSTRACT: 26 
Introduction: To investigate whether regional activation patterns in the vasti muscles 27 
differ between females with and without patellofemoral pain (PFP), and whether muscle 28 
activation patterns correlate with knee extension strength. 29 
Methods: Thirty-six females with PFP and 20 pain-free controls performed a 30 
standardized knee flexion-extension task. Activation of vastus medialis (VM) and 31 
lateralis (VL) was collected using high-density surface electromyography and analyzed 32 
using Principal component (PC) analysis. Spatial locations and temporal coefficients of 33 
the PCs, and percent variance they explain were compared between groups and 34 
between the concentric and eccentric phases of the movement. Correlations were 35 
assessed between PC features and knee extension strength. 36 
Results: The spatial weights of PC1 (general vasti activation) and PC2 (reflecting 37 
vastus-specific activation) were similar between groups (R>0.95). Activation patterns in 38 
PFP were less complex than controls. Fewer PCs were necessary to reconstruct 90% of 39 
the signal for PFP participants in the concentric phase (p<0.05), and the difference in 40 
bias of activation to VM (concentric phase) or VL (eccentric phase) was less between 41 
phases for PFP participants (p<0.05). Smaller difference invastus-specific activation in 42 
concentric and eccentric phases (less task specificity of VM/VL coordination) was 43 
related to greater maximal knee extension strength (p<0.05, R<-0.43). 44 
Conclusion: These data suggest PFP involves a simpler control strategy of VM and 45 
VL. The inverse association between task specificity and maximal knee extension 46 
strength suggests different presentations of PFP: lower knee extension strength but 47 
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VM/VL coordination task specificity comparable to controls, or knee extension strength 48 
comparable to controls but lower VM/VL coordination task specificity. 49 
 50 
KEYWORDS: Patellofemoral pain; EMG; quadriceps; muscle strength; Principal 51 
Component Analysis. 52 
53 
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INTRODUCTION: 54 
Patellofemoral pain (PFP) is common in young individuals engaged in sports. It is 55 
a complex, multifactorial syndrome with a pathogenesis that has not been fully 56 
elucidated. Historically, poor patellar tracking due to unbalanced activation of the vastus 57 
medialis (VM) and lateralis (VL) muscles has been considered to contribute to PFP (1). 58 
Although some studies support this hypothesis (2–4), others have not identified 59 
differences in timing or amplitude of activation of vastii muscles between symptomatic 60 
individuals and painfree controls (5, 6). A systematic review of the literature highlighted 61 
‘substantial and unexplained heterogeneity’ (7). This variability is likely to be explained 62 
by both physiological and methodological factors. 63 
A possible contributor to this variability is the potential differences in muscle 64 
activation between clinical presentations. Common clinical findings of PFP include lower 65 
knee extension strength (8), lower hip muscle strength (9), and higher dynamic foot 66 
mobility (10). In addition, interventions focused on different sites such as knee muscle 67 
strengthening (11), hip muscle strengthening (12) and foot orthoses (13) have all been 68 
shown to improve PFP symptoms in the short term. One possibility is that altered 69 
quadriceps activation is more common in people with PFP who also have weak knee 70 
extensors. To our knowledge, no studies have tested whether altered quadriceps 71 
activation is associated with features of PFP clinical presentation. 72 
Another factor that is likely to contribute to the unexplained variability of muscle 73 
activation in PFP relates to the methods used to quantify muscle activity. The technique 74 
most commonly used is surface electromyography (EMG), using one pair of electrodes 75 
placed on the belly of each vastus (2, 4, 5). This straightforward measure has a number 76 
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of limitations: for instance, due to variation in the location of the innervation zone 77 
relative to the electrodes, surface EMG amplitude differences up to 75% can be 78 
observed in the VM for electrodes positioned only 15 mm apart (14). Although this effect 79 
can be limited with normalization of EMG amplitude during isometric contractions (15), 80 
the VM innervation zone has been shown to shift under the electrodes as a function of 81 
knee angle (i.e. muscle length) (16), complicating the recording of representative 82 
surface EMG in dynamic contractions. In addition, as VM motoneurones innervate 83 
muscle fibres clustered within the muscle (17, 18), region-specific differences in VM 84 
activation can be observed both in reflex (19) and voluntary (16, 20) contractions; as 85 
regions within the vasti produce forces in different directions (21), differences in regional 86 
activation may result in different distribution of the forces applied to the patella. 87 
Recent advances in EMG technology allow for the placement of up several tens 88 
of electrodes on single muscles (high-density EMG, HDsEMG). As signals are collected 89 
from different locations of the muscle, HDsEMG helps to overcome some limitations of 90 
conventional surface EMG. For instance, it is possible to take into account the effect of 91 
the location of the innervation zone and other anatomical factors on the estimation of 92 
neuromuscular activation (14), and to describe the activation of regions within a muscle 93 
(16). Specifically, regional muscle activation can be identified using factorization 94 
algorithms such as principal component analysis (22). 95 
This exploratory study aimed to investigate whether VM and VL regional 96 
activation patterns, identified using high-density surface electromyography, differ 97 
between females with and without PFP. We hypothesized that, compared to painfree 98 
participants, those with PFP would demonstrate different coordination between VM and 99 
6 
 
VL as defined by spatial and temporal features of principal components extracted from 100 
VM and VL EMG activity during a standardized dynamic task. We also hypothesized 101 
that coordination between VM and VL would differ most in participants with lower knee 102 
extension strength. The research hypotheses were framed within contemporary theories 103 
on neuromuscular adaptations to pain, which predict that altered neuromuscular control 104 
is one factors that could sustain pain and function loss (23). 105 
 106 
METHODS: 107 
Participants: 108 
 Thirty-six females with symptomatic PFP and 20 healthy, sex-matched control 109 
participants were recruited from the local community and physiotherapy clinics. To be 110 
included in the PFP group, participants had to be: females, 19-35 years old, with retro- 111 
or peri-patellar knee pain of intensity equal or greater than 3/10 (on an 11-point numeric 112 
rating scale; 0 being ‘no pain’; 10 being ‘worst pain imaginable’) for at least 1 month 113 
aggravated by any of the following activities: sitting for long time periods, stairs, 114 
squatting, running, kneeling or jumping. They also needed to report pain or discomfort 115 
to at least one of the following tests: patellar palpation, patellar compression, resisted 116 
knee extension with knee close to full extension, isometric knee extension while 117 
applying pressure proximally to the patella. Control participants could not have had any 118 
knee pain in the last 12 months. For both groups, exclusion criteria were: previous 119 
lower-limb surgery, chronic neuromuscular disorders, or knee musculoskeletal 120 
disorders. All participants provided written informed consent before the start of the 121 
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experimental session. The study that was approved by the institution's Clinical 122 
Research Ethics Board. 123 
Age, body mass, height, duration of pain (self-reported), average pain intensity in 124 
the previous week (11-point numerical rating scale; 0 = ‘no pain’; 10 = ‘worst pain 125 
imaginable’) were obtained for each participant. Physical activity (General Physical 126 
Activity Questionnaire, (24)) and functional limitation (Anterior Knee Pain score, (25)) 127 
were estimated using validated questionnaires. The test leg was the most painful knee 128 
(if both were painful) or a random leg for controls.  129 
Clinical tests: 130 
 Dynamic foot mobility was assessed using the ‘foot mobility’ test. Following a 131 
validated and reliable procedure (26), foot arch height and midfoot width were 132 
measured using a caliper twice; while sitting and standing. The difference between 133 
measures taken in non-weightbearing and weightbearing positions was recorded and 134 
used to describe dynamic foot mobility. 135 
 Isometric knee extension strength was measured using a Biodex (System 4 Pro; 136 
Biodex Medical Systems, Shirley, NY). The hip and knee angles were standardized at 137 
85 and 45 (0 being full extension), respectively, and the participants were secured 138 
firmly to the chair. The resistance was applied approximately 2 cm proximal to the 139 
medial malleolus. The participants were asked to contract maximally the quadriceps 140 
muscle of the leg tested, reaching a maximal contraction over 1-2 s to ensure a smooth 141 
contraction and to maintain it for at least 3 s. This procedure was repeated 3 times with 142 
at least 1 minute of rest in-between trials. Verbal encouragement was provided at each 143 
trial. The highest peak torque of the three trials was used as maximal knee extension 144 
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strength (KES); analyses were also run on the KES value normalized to body mass 145 
(nKES). 146 
Protocol: 147 
 After a few repetitions to warm-up, participants performed 10 repetitive knee 148 
flexion-extension movements on the dynamometer from ~100 to 5 of knee flexion 149 
against a constant resistance set at 10% of their KES. A metronome standardized the 150 
pace at 3 s for each concentric knee extension, eccentric knee extension and rest.  151 
Data collection: 152 
 Similar to a previous study (16), the HDsEMG grids were placed according to 153 
anatomical references (Fig.1). The medial and lateral edges of VM and VL were 154 
identified using ultrasound imaging (LogicScan 64 LT-1T; Telemed, Vilnius, Lithuania) 155 
and were marked on the skin. As thickness of the subcutaneous tissues between the 156 
electrodes and the muscle may influence EMG recordings, a single ultrasound image 157 
was also taken in the proximal and distal region of both muscles, approximately in 158 
correspondence of the proximal and distal third of the grid array. VM and VL innervation 159 
zones were located using a linear electrode array (16 silver bar electrodes, 10-mm 160 
interelectrode distance; OTBioelettronica, Torino, Italy) and marked on the skin. Two 161 
HDsEMG grids (semidisposable adhesive matrix; OTBioelettronica) were placed on the 162 
skin so that the innervation zone aligned between the second and third column, and all 163 
the electrodes were placed of the target muscle. Each grid comprised 64 electrodes 164 
arranged in 5 columns and 13 rows with a single electrode missing in one of the 165 
corners, 8 mm inter-electrode distance and was held in place using bi-adhesive foam. 166 
With this electrode position, activation of different muscle regions can be observed 167 
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along the columns of the electrode grid, with negligible influence of changes in VM 168 
muscle architecture associated with changes in knee angle joint (16). Reference 169 
electrodes (2x3.5 cm; conductive hydrogel; Kendall, Covidien, Mansfield, MA) were 170 
placed on the patella and on the medial and lateral epicondyles. HDsEMG signals were 171 
collected in monopolar modality using an EMG amplifier (128-channel EMG-USB; 172 
OTBioelettronica, Torino, Italy). Signals were amplified 500-1000 times, filtered (band-173 
pass 10-750 Hz) and digitized at 2048 Hz using a 12-bit A/D converter. The knee 174 
position signal from the dynamometer was acquired simultaneously using the same 175 
amplifier. 176 
Data analysis: 177 
Ultrasound images were analysed using ImageJ (National Institutes of Health, 178 
Bethesda, Maryland, USA). The thickness of the subcutaneous tissues was measured 179 
as the distance between the skin and the most superficial edge of each muscle. All 180 
EMG analyses were run in Matlab 2016B (The MathWorks, Inc., Natick, MA, USA). A 181 
Butterworth filter (4th order, 10-400 Hz) was applied to the EMG signals before 182 
processing. Envelopes were calculated for each channel of both HDsEMG grids by full-183 
wave rectification and low-pass filtering at 8 Hz (Butterworth filter, 4th order). For each 184 
participant, the EMG values corresponding to 10-90 of the knee flexion-extension 185 
repetitions were extracted, and envelopes were normalized to the maximal envelope 186 
value of all channels across VM and VL. EMG envelopes were concatenated in two 187 
matrices of 128 EMG channels by N samples (N = 20 or N = 36 participants, multiplied 188 
by time samples), one for the PFP group and one for the control group.  189 
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As the analysis aimed to identify regional activation within the vasti, Principal 190 
Component Analysis (PCA, (27)) was applied to the HDsEMG dataset. Removing the 191 
mean from the data before PCA did not change the results of the study, so the data are 192 
presented for non-centered data. In line with previous studies that used separate 193 
factorization analyses for different conditions or groups (28, 29), PCA was applied 194 
separately for PFP and controls. As opposed to running PCA pooling all participants 195 
together, this approach enables identification of between-group differences in spatial 196 
weights; but limits between-group comparison of temporal coefficients to PCs that have 197 
similar spatial weights (R>0.95 in this study). PCA identifies clusters of channels with 198 
large covariance in time, factorizing the signal in principal components (PC); PCs 199 
represent the general activation pattern (PC1) or the major ways in which this pattern 200 
could be modulated (PC2-4) at any instant in time. Based on a recent study (22), it is 201 
expected that PC1 will have only positive values and will describe a general VM/VL 202 
activation; instead PC2 and above will have both positive and negative values, and will 203 
describe how the activation of regions within VM and VL is modulated (i.e.: 204 
increases/decreases compared to PC1). Preliminary analyses showed that the first four 205 
components described patterns of activation of the four regions of interest in this study 206 
(proximal/distal VM; proximal/distal VL), hence four PCs were considered. Each PC can 207 
be described by three indices (Fig. 2; Fig. 3): 1) spatial weights: the location of the 208 
channels where the PC is most represented; 2) temporal coefficient: the time profile of 209 
the activation of the PC; 3) the variance explained: how much of the variance of the 210 
signal is accounted for by the PCA. Each EMG envelope matrix M was factorized into 211 
128 PCs, each consisting of 128 weights and N coefficients. Spatial weights were 212 
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calculated as the eigenvectors ζ of the covariance matrix of M. Temporal coefficients 213 
were calculated as ζ T * M, which is the matrix product between the transposed 214 
eigenvectors and the EMG envelope matrix. PCs were sorted according to their 215 
eigenvalues. Spatial weights, temporal coefficients and variance explained of the PCs 216 
extracted from the PFP and from the control participants were compared between 217 
groups. For each participant, the temporal coefficients of the first 4 PCs corresponding 218 
to the concentric and the eccentric phase of each repetition were identified and 219 
averaged across knee angles and repetitions. The coefficient of determination (CD=1-220 
SSE/SST, where SSE is the sum of squared residuals, and SST is the total variance of 221 
the original signal) was used to calculate the variance explained for the first 4 PCs, 222 
separately for the concentric and eccentric phase of each participant. The mean total 223 
variance explained was calculated separately for the concentric and eccentric phase of 224 
the movement for each participant by varying the number of PCs between one and ten. 225 
The minimum number of PCs that accounted for at least 90% of the variance was 226 
identified for each participant, separately for the concentric and eccentric phase of the 227 
movement.  228 
Statistical analysis: 229 
All statistical analyses were performed using SPSS v.22 (IBM Inc., Armonk, NY, 230 
USA). Parametric tests were used if data were normally distributed and had equal 231 
variance, non-parametric tests were used if these assumptions were not met. 232 
Anthropometric parameters and clinical measures were compared between groups 233 
using independent T-tests. 234 
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 To investigate whether the thickness of subcutaneous tissues differed between 235 
females with and without PFP, the thickness was compared between groups (PFP or 236 
control, between-subject factor), muscles (VM or VL, within-subject factor) and locations 237 
(proximal or distal, within-subject factor) using a 3-way mixed model analysis of 238 
variance (ANOVA). 239 
 Pooling data across participants for the PCA, and using the PCA to distinguish 240 
differences in patterns of activation between groups with and without PFP pain requires 241 
the general patterns of activity to be similar within the participants for each group. We 242 
tested this by applying PCA to individual participants (separately for females with and 243 
without PFP) and then evaluating the Pearson correlation coefficients between the 244 
spatial weights for each participant with the mean spatial weights for their group. 245 
 The three descriptors of muscle activation identified with PCA were compared. 246 
The complexity of muscle activation patterns is reflected by the number of PCs that 247 
accounted for at least 90% of the variance, and this was compared between groups 248 
using Wilcoxon tests, separately for the concentric and the eccentric phase of the 249 
movement. To describe whether the spatial localization of the PCs was similar between 250 
groups, Pearson correlation was run on the spatial weights of the first four PCs between 251 
groups. PCs with spatial weights that correlated with R>0.95 were considered similar 252 
between groups. When PCs for the two groups were not significantly correlated, the 253 
maps of spatial weights across electrode sites was view qualitatively to identify 254 
differences in distribution that would explain the between-group difference. For PCs with 255 
a similar spatial structure (R>0.95), it was considered valid to compare the temporal 256 
coefficient of activation of the vasti muscles between groups and phases (concentric or 257 
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eccentric, within-subject factor) using 2-way mixed model ANOVA, separately for each 258 
component. Student’s t-tests with Bonferroni correction for multiple comparisons were 259 
used for post-hoc comparisons. For PCs with spatial structure that differed between 260 
groups, temporal coefficients were compared between the phases (concentric and 261 
eccentric) only using paired Student’s t-tests. 262 
 To identify any relation between clinical measures and EMG dysfunction, 263 
Spearman correlation was used to test associations between the EMG indices that were 264 
significant in the between-group comparisons and KES, nKES, dynamic midfoot width 265 
and dynamic foot height. Statistical significance was set at p<0.05. 266 
 267 
RESULTS: 268 
Participant characteristics and clinical tests: 269 
The two groups did not differ for age (participants PFP: 27±4; controls: 26±4 270 
years old, p=0.38), weight (62±9 vs. 58±9 kg, p=0.10), height (166±8 vs. 168±9 cm, 271 
p=0.59), or physical activity level (4018±2961 vs. 3153±2034 METmin/week, p=0.20). A 272 
significant difference was identified for body mass index, although the average value for 273 
both groups fell within the normal range (22.5±5.2 vs. 20.6±1.7, p<0.01). Participants 274 
with PFP reported a history of knee pain for 12-60 (interquartile range) months, average 275 
pain of 4.1±1.3 in the previous week and their Anterior Knee Pain Score was 74.8. Both 276 
KES (116.5±30.6 vs. 135.3±32.9 Nm, p<0.05) and nKES (1.88±0.54 vs. 2.31±0.41 277 
Nm/kg, p<0.01) were lower in females with PFP compared to controls. Foot height 278 
mobility (14.3±1.7 vs. 11.8±2.9 mm, p<0.01) but not midfoot width (8.8±4.0 vs. 8.2±1.7 279 
mm, p=0.44) was higher in females with PFP compared with controls. 280 
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Subcutaneous tissue thickness: 281 
 Ultrasound measurement of thickness of subcutaneous tissues did not differ 282 
between groups (PFP: 9.2±3.5 mm; controls: 8.6±3.5 mm, p=0.42). Subcutaneous 283 
tissues were thicker over VL than VM (9.1±3.4 vs 8.0±3.4 mm; main effect of muscle, 284 
p<0.01), and proximally than distally (9.4±3.8 vs 7.7±2.8 mm; main effect of location, 285 
p<0.001). No interactions were observed (p>0.25). 286 
Number of principal components: 287 
A lower number of PCs was needed to explain 90% of the variance for 288 
participants with PFP (median: 2; 25th-75th percentiles: 2-3; Fig. 4) than for controls (3; 289 
2-4.5) in the concentric phase of the movement (p<0.05). No differences were observed 290 
in the eccentric phase of the movement (p=0.20). These results were confirmed when 291 
the variance explained (calculated by applying PCA on each participant separately) was 292 
compared between groups (p<0.05). Given that four PCs explained 92.2±4.0% and 293 
94.7±2.4% for controls and participants with PFP respectively (N=20 and N=36; figure 294 
S1, variance explained by different number of PCs), all remaining analyses were 295 
performed using the first four PCs. 296 
Spatial features of principal components: 297 
The median correlation coefficient between spatial weights extracting using PCA 298 
separately for each participant and their group average spatial weight was high (median 299 
(interquartile range); PC1: 0.75 (0.67-0.85); PC2: 0.97 (0.94-0.99); PC3: 0.80 (0.72-300 
0.88); PC4: 0.81 (0.47-0.88); all N=56), supporting the use of PCA on group data. Visual 301 
assessment of the spatial location of the PCs enables the determination of regional 302 
activation patterns described by each PC. PC1 which we refer to as PC1General activation, 303 
15 
 
had positive spatial weights for all the channels, describing simultaneous activation of 304 
both vasti, and was similar between groups (R = 0.96). The PCs other than PC1General 305 
activation had both positive and negative values in their spatial weights and temporal 306 
coefficients, and described modulation (increase and decrease of activation) of 307 
PC1General activation (22). In control participants (Fig. 2), PC3 has positive spatial weights 308 
(light shading) in the distal region of both VM and VL, and negative values (dark 309 
shading) proximally. When the temporal coefficients are positive, muscle activation 310 
increases in the channels with positive spatial weights (distally) and decreases where 311 
they are negative (proximally); by contrast, when the temporal coefficients are negative, 312 
muscle activation increases proximally (channels with negative spatial weights) and 313 
decreases distally (channels with negative spatial weights). Taken together, PC3 in 314 
controls describes co-activation of the distal region of VM and VL (when the temporal 315 
coefficients are positive; start of concentric and end of eccentric) and of the proximal 316 
regions (when the temporal coefficients are negative; start of concentric and end of 317 
eccentric); for this reason, it was referred to as PC3Vasti co-activation. PC3 Vasti co-activation 318 
differed between groups (R = 0.75); for PPF PC3 described regional activation within 319 
the VL that was similar to controls, but no concomitant regional activation in VM. In 320 
controls PC4 described the co-activation of proximal VL and distal VM or vice versa 321 
(Fig. 2), and was referred to as PC4Proximal-distal vasti co-activation. This was different in PFP (R 322 
= 0.73) where PC4Proximal-distal vasti co-activation identified regional activation within the VM 323 
similar to controls, but did not represent VL activation (Fig. 3). The spatial weight values 324 
for PC2, were positive for VM and negative for VL, hence describing a bias to 325 
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contraction for VM from this PC, thus referred to as, PC2Vastus-specific activation. The spatial 326 
distribution of PC2Vastus-specific activation was similar between groups (R = 0.99).  327 
Temporal features of principal components: 328 
 As the spatial weights of PC3Vasti co-activation and PC4Proximal-distal vasti co-activation 329 
differed between groups in their location, temporal coefficients could not be directly 330 
compared for these PCs. Thus, only temporal coefficients of PC1General activation and 331 
PC2Vastus-specific activation were compared between groups. PC1General activation was more 332 
active in the concentric than the eccentric phase of the movement (main effect of phase, 333 
p<0.001; Fig. 5) and this did not differ between groups (main effect; p=0.14, interactions 334 
p=0.99). A significant interaction was identified between groups and phases for the 335 
temporal coefficient of PC2Vastus-specific activation (p<0.05, Fig. 5), meaning that redistribution 336 
of VM/VL activation between the concentric and the eccentric phase of the movement 337 
was lower in participants with PFP compared to controls (i.e.: participants with PFP had 338 
more co-activation of VM and VL). Both groups showed negative PC2Vastus-specific activation 339 
temporal coefficients (i.e. activation to expression of PC2, and thus bias to VL 340 
activation) in the concentric phase of the movement and positive PC2Vastus-specific activation 341 
temporal coefficients (bias to VM activation) in the eccentric phase of the movement; 342 
this resulted in significantly lower temporal coefficients during the concentric phase than 343 
the eccentric phase of the movement (p<0.001). In controls, the temporal coefficients of 344 
PC3Vasti co-activation (0.02±0.26 and 0.03±0.23, p=0.67) or PC4Proximal-distal vasti co-activation 345 
(0.01±0.20 and 0.02±0.17, p=0.36) did not differ between concentric and eccentric 346 
phase of the movement. In PFP, PC3Within-VL activation was lower in the concentric than the 347 
eccentric phase of the movement (-0.02±0.26 and 0.03±0.17, p<0.05); a similar 348 
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tendency, although not-significant, was observed for PC4Within-VM activation (0.00±0.15 and 349 
0.03±0.17, p=0.06). 350 
Associations between clinical tests and neuromuscular activation patterns: 351 
 Correlations were assessed separately for participants with and without PFP to 352 
investigate associations between the EMG indices that were found to differ significantly 353 
between groups (temporal coefficients of PC2Vastus-specific activation; number of PCs 354 
necessary to reconstruct 90% of the variance in the concentric phase of the movement; 355 
see above) and clinical measures (KES; nKES; midfoot width; foot height). One 356 
individual was identified as a potential outlier and this was statistically confirmed by 357 
inputting the data to a linear regression model. For that participant, Cook’s distance 358 
measures were 0.93 (temporal coefficients of PC2Vastus-specific activation and nKES) and 0.95 359 
(temporal coefficients of PC2Vastus-specific activation and KES), much higher than the cut-off 360 
value for outliers (4/N=0.11). After exclusion of data for that individual, an inverse 361 
correlation was identified between temporal coefficients of PC2Vastus-specific activation during 362 
the eccentric phase of the movement and KES (p=0.01, R=-0.43; nKES: p=0.001, R=-363 
0.52; Fig. 6), that is, participants with a lower redistribution of activation between VL and 364 
VM had higher KES. Association in the same direction was observed for temporal 365 
coefficients of PC2Vastus-specific activation during the concentric phase of the movement, 366 
although the strength of the association was lower (KES: p<0.05, R=-0.38; nKES: 367 
p=0.09, R=-0.3). These associations were not observed in females without PFP 368 
(p>0.12, R<0.36). No other significant correlations were identified. 369 
 370 
DISCUSSION: 371 
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 These data show that the regional activation within VM and VL during a low-force 372 
dynamic knee extension task differs between females with and without PFP. The lower 373 
number of PCs needed to reconstruct 90% of the variance (i.e. fewer components 374 
required to explain the pattern of EMG activity) for those with PFP than controls, and the 375 
lesser difference in bias to VM or VL between the concentric and eccentric task phases, 376 
both suggest a simpler control strategy of vasti muscle coordination in PFP. The data 377 
also show lower co-activation between VM and VL in PFP than in controls; PC3 and 378 
PC4 represented activation of only VM or VL in the PFP group, unlike the controls 379 
where these PCs represented coordination between the vasti muscles. The inverse 380 
association between task specificity of VM/VL coordination and maximal knee extension 381 
strength in PFP demonstrates a spectrum of presentations with lower knee extension 382 
strength but VM/VL coordination that was similar to controls at one end, and high knee 383 
strength but compromised VM/VL coordination at the other end. 384 
 Altered VM and VL activation patterns have been observed in PFP in this study. 385 
During the concentric phase of the knee extension, vasti muscle activation of females 386 
with PFP can be explained by two main activation patterns, i.e.: global activation (PC1) 387 
and redistribution between VM and VL (PC2). To reconstruct the signal to a similar 388 
extent (i.e. explain the same amount of variation), the control participants required 389 
inclusion of an additional activation pattern that represented co-activation of distal or 390 
proximal regions of VM and VL. This observation suggests that activation of the VM and 391 
VL in PFP participants included a smaller component of EMG that controlled 392 
coordination between medial and lateral forces during muscle shortening. Similar 393 
findings of simpler control in association with a musculoskeletal condition has been 394 
19 
 
reported for the deep hip external rotator muscles in participants with femoro-acetabular 395 
impingement syndrome (28). During the eccentric phase, the number of PCs did not 396 
differ between groups; however, the additional activation patterns in PFP represented 397 
regional activation of a single vastus muscle, rather than coordination between of 398 
regions between VM and VL. This concurs with observation of less synchronous 399 
activation of motor units in VM and VL in PFP (3) and other studies that identified 400 
differences in timing and amplitude of vasti activation using conventional bipolar surface 401 
EMG (4, 30). 402 
Taken together, the present results suggest that a PC that accounts for co-403 
activation between regions of VM and VL explains an important component of pattern 404 
variance in controls but not in PFP. Consistent with proposed theories of patellofemoral 405 
joint control (1, 31), this co-activation between VM and VL could be interpreted to 406 
represent a strategy coordinate forces for optimal patellar tracking in controls. Females 407 
with PFP used patterns of EMG that involved lesser modulation of regional activation 408 
within each vastus, but instead used overall co-activation plus components that account 409 
for bias of activity to only VM or VL. It has been shown in vivo that load applied by each 410 
vastus muscle in isolation influences the distribution of forces applied to the patella (21, 411 
32). It is plausible that this would be impacted by the distribution of activity between the 412 
vasti muscles and differences in this pattern between controls and participants with PFP 413 
could be expected to alter patellar kinematics and pressure distribution within the 414 
patellofemoral joint observed in PFP (30, 33).  415 
 An interesting observation was the between-group differences in the task 416 
specificity of the relative activation of VM and VL during phases of dynamic knee 417 
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extension. As control participants showed a bias towards VL activation during the 418 
concentric phase and towards VM activation during the eccentric phase of the knee 419 
extension movement, this may have significance for differences in patellar tracking and 420 
joint loading between the different tasks. This between-muscle redistribution of EMG 421 
was limited in PFP, especially during the eccentric phase of the movement. Reduced 422 
task specificity has also been observed in some other musculoskeletal conditions, such 423 
as low back pain (34) and may imply a loss of the fine-tuning of the control of forces in 424 
the patellofemoral joint. Te and colleagues (35) have recently shown that the 425 
representations of the individual heads of the quadriceps on the motor cortex are closer 426 
together for individuals with PFP than healthy controls; similar to what was suggested in 427 
other studies (36, 37). Although speculative, such merging of the muscle 428 
representations at the cortical level may underlie a lesser capacity to modulate 429 
coordination of vasti muscles in a task specific manner. However, we cannot interpret 430 
from our data where in the nervous system changes might be occurring (e.g. cortical, 431 
spinal, etc) and further work is required. 432 
The temporal coefficients of PC1General activation suggest a greater contribution of 433 
this PC during the concentric than eccentric phase of the movement, without a 434 
difference between groups. This suggests that the lower muscle activation in the 435 
eccentric versus the concentric phase of movement (38) is preserved in PFP and would 436 
be expected base on physiological property of muscle to require less EMG activation to 437 
generate equivalent force in eccentric contractions. The co-activation patterns (PC3Vasti 438 
co-activation and PC4Proximal-distal vasti co-activation) in controls were equally observed in the 439 
concentric and eccentric phase of the movement, suggesting that the within-muscle 440 
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redistribution of activation represented by these PCs occurred similarly for both tasks. 441 
Unlike the control participants, the within-muscle regional activation patterns (PC3Within-442 
VL activation and PC4Within-VM activation) in PFP indicated preferential activation of one muscle 443 
rather than co-activation, specifically the distal VL (PC3 Within-VL activation) and VM (PC4 444 
Within-VM activation, trend) in the eccentric phase of the movement, similar to previous 445 
preliminary observations in the VM (16). This suggests that preferential activation of 446 
vasti regions that have larger potential to contribute to medio-lateral patellar forces 447 
mainly occurs in the eccentric phase of the movement. Although this aspect of the 448 
motor pattern was more task specific for PFP and controls, and is not consistent with 449 
our suggestion of a simplified control strategy in this group, it must be taken together 450 
with the fact that these PCs only explain a small percentage of the variance. 451 
Regardless, this observation remains interesting because, in contrast to control 452 
participants, this within-muscle redistribution was not co-activation and occurred at 453 
different times for two muscles. These findings highlight differences in how females with 454 
and without PFP activate the distal regions of VM and VL in dynamic contractions. 455 
 Contrary to our hypothesis, participants with lower knee extension strength did 456 
not show the largest differences in neuromuscular control (lower redistribution between 457 
VM and VL). Instead, an inverse association was observed – the weaker participants 458 
had a neuromuscular activation pattern more like controls. A recent classification 459 
identified two categories of adaptation to pain: major “movement avoidance” patterns 460 
and subtle “redistribution within and between muscle” (39). The current data provide an 461 
interesting new observation – we propose an interpretation that the adaptations in 462 
females with PFP are distributed along a continuum, with some presenting with a 463 
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“reduced force output” strategy, whereas others present with subtle differences in 464 
muscle coordination. There is of course a proportion of the PFP group with strength and 465 
neuromuscular activation between these two extremes. The lower force output may be 466 
associated not only with neuromuscular factors, but also to changes in muscle structural 467 
parameters (40). Regardless, these two different strategies may present with different 468 
consequences for long-term health of the patellofemoral joint. 469 
Because of the cross-sectional design of the study, it is not possible to define 470 
whether changes in force output and neuromuscular activation are a cause or 471 
consequence of PFP, or whether in the long term the effects on patellofemoral joint 472 
health are different. Regardless, it is tempting to speculate about the potential clinical 473 
implications as it may be helpful to identify subgroups of participants that respond 474 
differently to interventions. Specifically, females with PFP and lower knee extension 475 
strength may benefit from interventions that focus on quadriceps strengthening, 476 
whereas exercises that target motor control might be beneficial for females with PFP 477 
and knee extension strength similar to controls, but concomitant differences in 478 
coordination of vasti muscles. Future studies should investigate whether interventions 479 
matched to these deficits in females with PFP have better clinical outcomes than 480 
treatments that are not matched. 481 
Due to conduction volume of soft tissues, surface electromyographic signals are 482 
known to be influenced by crosstalk. One of the main contributors to crosstalk in the 483 
surface EMG is the thickness of subcutaneous tissues. Despite larger BMI in females 484 
with PFP, ultrasound measures of subcutaneous tissue thickness over VM and VL did 485 
not differ between groups (average difference: 0.6 mm). For this reason, any effects of 486 
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subcutaneous tissue thickness on the crosstalk in the surface EMG activation patterns 487 
would be similar between groups. Additionally, crosstalk from far sources is likely to be 488 
observed as similar EMG amplitude fluctuations in most channels of the grid, 489 
represented by PC1 in this study, while the other PCs representing regional activation 490 
may be less influenced by crosstalk. While the amount of crosstalk present in this 491 
dataset cannot be precisely defined, the absence of differences between group in 492 
thickness of subcutaneous tissue and the use of PCA suggest that crosstalk had a 493 
minimal influence on the results of this study. 494 
 In conclusion, females with PFP have simpler VM and VL activation strategies, 495 
observed as lower co-activation of regions between VM and VL and lower redistribution 496 
of activation from VL to VM when the concentric and eccentric phases of the knee 497 
extension are compared. As VM/VL redistribution was inversely correlated to maximal 498 
knee extension strength, we suggest two different presentations of PFP: prevalent lower 499 
knee extension strength or prevalent lower redistribution between VM and VL. These 500 
dysfunctions may be preferentially targeted by different interventions, potentially 501 
resulting in improved clinical outcomes. 502 
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FIGURES: 630 
631 
Figure 1: Experimental set-up. Left: placement of the electrode grids on vastus medialis 632 
(VM) and vastus lateralis (VL). Gray squares identify the innervation zones. Right: 633 
example of knee joint angle (thick gray line) and monopolar surface EMG collected from 634 
proximal (P) and distal (D) locations within VM and VL. 635 
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 636 
Figure 2: Example of PCA analysis of high-density EMG signals for a control participant. 637 
Left: 8 of the 128 EMG envelopes used for the PCA from 3 repetitions of a control 638 
participant; light and dark gray boxes identify the concentric (C) and eccentric (E) phase 639 
of the movement (10-90). Middle: spatial weights of PC1-4 (from PCA using data for all 640 
control participants); light and dark shades identify positive and negative weights 641 
respectively. PC1General activation shows positive weights for both VM and VL; PC2Vastus-specific 642 
activation shows positive weights of VM and negative weights for VL; PC3Vasti co-activation 643 
shows positive weights for both muscles distally and negative weights proximally; 644 
PC4Proximal-distal vasti co-activation shows positive weight for VM distally and VL proximally, and 645 
negative weights for VM proximally and VL distally. Right: temporal coefficients 646 
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calculated from the same three repetitions on the left, and average temporal coefficients 647 
calculated over 10 repetitions, separately for concentric and eccentric phase. Inspection 648 
of coefficients suggests that expression of PC1General activation increases towards the end 649 
of concentric motion and beginning of eccentric motion. The converse is shown for 650 
PC2Vastus-specific activation (and PC3Vasti co-activation to a lesser extent); lower towards end of 651 
concentric and beginning of eccentric. Some differences were observed between 652 
phases and groups, when analyses are appropriate (i.e. PC1General activation and PC2Vastus-653 
specific activation which both had no difference in spatial coefficients between groups). 654 
655 
Figure 3: Example of PCA analysis of high-density EMG signals for a participant with 656 
PFP. Left: 8 of the 128 EMG envelopes used for the PCA from 3 repetitions of a control 657 
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participant; light and dark gray boxes identify the concentric (C) and eccentric (E) phase 658 
of the movement (10-90). Middle: spatial weights of PC1-4 (from PCA using data for all 659 
the participants with PFP); light and dark shades identify positive and negative weights 660 
respectively. Weights for PCs are similar to that for control participants (see Fig. 2), 661 
except, unlike controls, PC3Within-VL activation and PC4Within-VM activation reflect activity of single 662 
muscles rather than a pattern of coordination between muscles (no regional variation in 663 
VM in PC3Within-VL activation or VL in PC4Within-VM activation). Right: temporal coefficients 664 
calculated from the 3 repetitions on the left, and average temporal coefficients 665 
calculated over 10 repetitions, separately for concentric and eccentric phase. Only 666 
temporal coefficients for PC1General activation and PC2Vastus-specific activation were compared 667 
between groups for both control and PFP groups. 668 
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 669 
Figure 4: Comparison between the minimum number of PCs that explains at least 90% 670 
of the variance in the concentric (left) or eccentric (right) phase of the movement. * 671 
p<0.05 672 
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 673 
Figure 5: Figure 5: Comparison of mean temporal coefficients of PC1General activation (left) 674 
and PC2Vastus-specific activation (right). The contribution of PC1General activation was larger during 675 
the concentric than the eccentric phase of the movement, regardless of the group. For 676 
both groups, PC2Vastus-specific activation was negative (prevalent VL activation) in the 677 
concentric and positive (prevalent VM activation) in the eccentric phase of the 678 
movement; however, this redistribution was smaller in the PFP than in control 679 
participants (interaction effect identified by the arrows). * p <0.05; ** p <0.01 680 
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 681 
Figure 6: Scatter plot of KES and PC2Vastus-specific activation (eccentric phase) in females with 682 
PFP; higher values indicate preferential VM activation during the eccentric phase of the 683 
contraction. The data point of the participant excluded from this analysis was crossed. 684 
Spearman R identified a moderate inverse correlation between the two variables. 685 
 686 
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687 
Figure S1: Variance explained by different number of PCs. Gray and black lines identify 688 
participants with and without PFP. Circles and squares identify concentric and eccentric 689 
phases of the movement. 690 
